Halozyme Therapeutics, Inc. (HALO)
66.61
-0.75
(-1.11%)
USD |
NASDAQ |
Mar 06, 10:15
Halozyme Therapeutics Market Cap : 7.861B for March 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 283.36B |
| Johnson & Johnson | 569.94B |
| Skye Bioscience, Inc. | 23.16M |
| AIM ImmunoTech, Inc. | 2.357M |
| Stryker Corp. | 136.86B |
Market Cap Related Metrics
| PE Ratio | 26.73 |
| PS Ratio | 5.852 |
| Price to Book Value | 161.04 |
| Price to Free Cash Flow | 12.68 |
| Price | 66.61 |
| Earnings Yield | 3.74% |
| Operating PE Ratio | 10.01 |
| Normalized PE Ratio | 14.51 |